7 Amendments of Giorgos GRAMMATIKAKIS related to 2017/2951(RSP)
Amendment 3 #
Recital B
B. whereas cost of a full vaccines package for one child, even at the lowest global prices, has increased by a factor of 68 from 2001 to 2014; whereas this price increase is unjustifiable and incompatible with the Sustainable Development Goal to ensure healthy lives and promote well- being at all ages;
Amendment 26 #
Paragraph 4
4. Welcomes the active engagement of the Commission on the issue of vaccination and the inclusmplementation of a Joint Action Plan on vaccination, co- funded by the EU Health Programme, in the 2018 Commission Work Programm from Spring 2018, with the participation of 20 Member States; regrets that 8 Member States decided not to participate;
Amendment 44 #
Paragraph 9 a (new)
9 a. Believes that the initiative of the European Commission regarding the Strengthened cooperation against vaccine preventable diseases, due to be presented the second quarter of 2018 in the form of Council Recommendations on supporting Member States in implementing vaccination programmes, reducing vaccine hesitancy strengthening the supply of vaccines and overall improving vaccination coverage, is a good step; Calls the European Commission and the Council to take into account the position of the European Parliament in the drafting of the recommendations;
Amendment 58 #
Paragraph 12 a (new)
12 a. Emphasises the need for inclusive, factual and science-based information to citizens; calls on the Commission and Member States to facilitate dialogue with stakeholders from civil society, grass root movements, academia, media and national health authorities in order to combat unreliable, misleading and unscientific information on vaccination;
Amendment 64 #
Paragraph 13
13. Is concerned about the high prices of some life-saving vaccines and that this risks further exacerbating existing health inequalities in society; calls on the Commission and the Member States to implement the measures called for in the European Parliament’s report of 14 February 2017 on EU options for improving access to medicines;
Amendment 66 #
Paragraph 13
13. Is concerned about the high prices of some life-saving vaccines; calls on the Commission and the Member States to implement the measures called for in the European Parliament’s report of 14 February 2017 on EU options for improving access to medicines and include them in the upcoming Council Recommendations;
Amendment 73 #
Paragraph 15 a (new)
15 a. Deplores the persisting inequalities between women and men in participation in clinical trials, which may hinder medicinal research and the development of vaccines for diseases where a majority of patients are women; calls on the Commission and Member States to take measures to eliminate this discriminating gender gap;